World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
31849
World Ranking
9348
National Ranking
910

Neuroscience

D-Index
97
Citations
31797
World Ranking
830
National Ranking
95

Gus A. Baker publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Gus A. Baker sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 353 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Gus A. Baker D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Gus A. Baker sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 97 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Gus A. Baker is affiliated with the University of Liverpool in the United Kingdom and has a research focus within the field of Medicine. Their work spans several subfields, including Psychiatry and Mental Health, Pediatrics, Perinatology and Child Health, Cognitive Neuroscience, Genetics, and Neurology.

The primary focus of Baker's research relates to epilepsy, reflected in the topics they have explored such as Epilepsy Research and Treatment, Pharmacological Effects and Toxicity Studies, Psychosomatic Disorders and Their Treatments, Functional Brain Connectivity Studies, Hemoglobinopathies and Related Disorders, Drug Transport and Resistance Mechanisms, and Health Systems, Economic Evaluations, and Quality of Life.

Among recent publications, Baker has contributed to studies published between 2021 and 2024 in notable venues. These works include:

  • The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial, 2021, The Lancet
  • The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial, 2021, The Lancet
  • National plans and awareness campaigns as priorities for achieving global brain health, 2024, The Lancet Global Health
  • Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET), 2022, Trials
  • Development of an International Standard Set of Outcomes and Measurement Methods for Routine Practice for Adults with Epilepsy: The International Consortium for Health Outcomes Measurement Consensus Recommendations, 2024, Epilepsia

Baker frequently collaborates with researchers including Anthony G Marson, Richard Appleton, Melissa Maguire, Donna Walsh, and John Paul Leach.

Their scholarly work is often published in journals that focus on neurological and psychological conditions, with Epilepsia and Epilepsy & Behavior being the most common venues for their publications. Others include The Lancet, Frontiers in Psychology, and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

    Anthony G Marson;Asya M Al-Kharusi;Muna Alwaidh;Richard Appleton

  • Quality of life of people with epilepsy: a European study.

    Gus A. Baker;Ann Jacoby;Deborah Buck;Carlos Stalgis

  • The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

    Anthony G Marson;Asya M Al-Kharusi;Muna Alwaidh;Richard Appleton

  • Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

    Kimford J Meador;Gus A Baker;Nancy Browning;Morris J Cohen

  • Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs

    Kimford J. Meador;Gus A. Baker;Nancy Browning;Jill Clayton-Smith

  • Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force.

    W. Curt LaFrance;W. Curt LaFrance;Gus A. Baker;Rod Duncan;Laura H. Goldstein

  • The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study.

    Ann Jacoby;Gus A. Baker;Nick Steen;Pauline Potts

  • The longer term outcome of children born to mothers with epilepsy

    N Adab;U Kini;J Vinten;J Ayres

  • Epilepsy and social identity: the stigma of a chronic neurological disorder.

    Ann Jacoby;Dee Snape;Gus A Baker

  • The stigma of epilepsy: a European perspective.

    Gus A. Baker;Jayne Brooks;Debbie Buck;Ann Jacoby

  • Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review.

    Rod S. Taylor;Josemir W. Sander;Rebecca J. Taylor;Gus A. Baker

  • The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs

    Rebecca Louise Bromley;George E Mawer;Maria Briggs;Christopher Cheyne

  • Outcomes of add-on treatment with lamotrigine in partial epilepsy.

    D. Smith;G. Baker;G. Davies;M. Dewey

  • Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial

    Frank G. Gilliam;A. J. Fessler;G. Baker;V. Vahle

  • Psychogenic non-epileptic seizures--definition, etiology, treatment and prognostic issues: a critical review.

    N.M.G. Bodde;J.L. Brooks;G.A. Baker;P.A.J.M. Boon

  • In utero antiepileptic drug exposure: Fetal death and malformations

    K. J. Meador;G. A. Baker;Richard Finnell;L. A. Kalayjian

  • Patients' Experiences of Injury as a Result of Epilepsy

    Deborah Buck;Gus A. Baker;Ann Jacoby;David F. Smith

  • Autism spectrum disorders following in utero exposure to antiepileptic drugs.

    R. L. Bromley;G. Mawer;J. Clayton-Smith;G. A. Baker

  • IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study

    Gus A. Baker;Rebecca L. Bromley;Maria Briggs;Christopher P. Cheyne

  • The psychosocial burden of epilepsy.

    Gus A. Baker

Frequent Co-Authors

Jill Clayton-Smith
Jill Clayton-Smith University of Manchester
Anthony G Marson
Anthony G Marson University of Liverpool
David Chadwick
David Chadwick University of Liverpool
Kimford J. Meador
Kimford J. Meador Stanford University
Joyce Liporace
Joyce Liporace Thomas Jefferson University
Page B. Pennell
Page B. Pennell University of Pittsburgh
David W. Loring
David W. Loring Emory University
Laura H. Goldstein
Laura H. Goldstein King's College London
Albert P. Aldenkamp
Albert P. Aldenkamp Eindhoven University of Technology
Michael Privitera
Michael Privitera University of Cincinnati

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gus A. Baker

Trending Scientists